Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clinical High Risk”

1,980 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,980 results

Post-approval studies (Phase 4)UnknownNCT04738955
What this trial is testing

Efficacy and Safety of Micafungin for Injection in Prevention and Treatment of Fungal Infection in Hematological Tumors

Who this might be right for
Hematological Tumors Patients With High Risk Factors of Invasive Fungal Disease
Shandong Provincial Hospital 230
Not applicableNot Yet RecruitingNCT07569978
What this trial is testing

Efficacy and Safety of High-Concentration 35 kDa Hyaluronan Gel for Herpes Zoster-Associated Pain

Who this might be right for
Herpes ZosterZoster-Associated PainPostherpetic Neuralgia+2 more
Nakhia Impex LLC 30
Not applicableUnknownNCT03731923
What this trial is testing

Abbreviated MRI for HCC Surveillance

Who this might be right for
Hepatocellular CarcinomaLiver CirrhosisChronic Hepatitis
Seoul National University Hospital 257
Not applicableStudy completedNCT04038788
What this trial is testing

Add-on HD Hf-tRNS Over Bilateral DLPFC for Treating Patients With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderPsychotic Symptoms+6 more
Tri-Service General Hospital 36
Large-scale testing (Phase 3)Active Not RecruitingNCT03022825
What this trial is testing

QUILT-3.032: A Multicenter Clinical Trial of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With BCG Unresponsive High Grade Non-Muscle Invasive Bladder Cancer

Who this might be right for
Bladder Cancer
ImmunityBio, Inc. 190
Not applicableStudy completedNCT05988359
What this trial is testing

Quantitative Evaluation of Aerosols Produced in the Dental Office

Who this might be right for
Aerosol DiseaseCaries,Dental
Wroclaw Medical University 60
Post-approval studies (Phase 4)Study completedNCT04691726
What this trial is testing

Impact of Intra- and Postoperative Continuous Infusion of Lidocaine on Analgesia in Vascular Anaesthesia

Who this might be right for
Abdominal Aorta AneurysmAbdominal Aorta AtheromaSurgery+1 more
Łukasz Krzych 87
Not applicableNot Yet RecruitingNCT06192147
What this trial is testing

The Phenotype and Clinical Intervention of High BCAA Type of PCOS

Who this might be right for
Polycystic Ovary Syndrome
Peking University Third Hospital 400
Not applicableNot Yet RecruitingNCT06905938
What this trial is testing

Comparing Monofocal IOLs in Highly Myopic Cataract Patients

Who this might be right for
Cataract
Wenzhou Medical University 60
Not applicableLooking for participantsNCT05321368
What this trial is testing

A Cardiometabolic Health Program Linked With Clinical-Community Support and Mobile Health Telemonitoring to Reduce Health Disparities

Who this might be right for
HypertensionHigh Blood PressureDiabetes+1 more
Johns Hopkins University 425
Large-scale testing (Phase 3)Active Not RecruitingNCT04639180
What this trial is testing

Evaluate Camrelizumab Plus Rivoceranib (Apatinib) as Adjuvant Therapy in Patients With Hepatocellular Carcinoma (HCC) at High Risk of Recurrence After Curative Resection or Ablation

Who this might be right for
Hepatocellular Carcinoma (HCC)
Jiangsu HengRui Medicine Co., Ltd. 687
Not applicableStudy completedNCT05273203
What this trial is testing

The Influence of Football Training as a medicine_FIM_UTH

Who this might be right for
Soccer TrainingBody CompositionPhysical Activity+1 more
University of Thessaly 48
Testing effectiveness (Phase 2)Looking for participantsNCT07474324
What this trial is testing

Disitamab Vedotin Combined With SOX Regimen Versus SOX Alone as Adjuvant Therapy for HER2-Moderate/High Expressing Stage Ⅲ Gastric Cancer: A Prospective, Multicenter, Randomized, Phase Ⅱ Clinical Trial

Who this might be right for
GC/GEJC
The First Affiliated Hospital with Nanjing Medical University 124
Not applicableActive Not RecruitingNCT03613246
What this trial is testing

NVT ALLEGRA TAVI System TF in Failing Calcified Aortic Heart Valves in a Real-world Patient Population

Who this might be right for
Transcatheter Aortic Valve Implantation
NVT GmbH 346
Very early researchActive Not RecruitingNCT05880862
What this trial is testing

Comparative Effectiveness of Initial OAB Treatment Options Among Older Women at High Risk of Falls

Who this might be right for
Urinary Bladder, OveractiveUrinary IncontinenceAccidental Falls
The University of Texas Medical Branch, Galveston 48
Early research (Phase 1)Looking for participantsNCT07348042
What this trial is testing

Study of RGL-270 Single Drug and Combined With Adebelimab in Patients in Patients at High Risk of Recurrence After Radical Treatment of Malignant Solid Tumors

Who this might be right for
Tumor, Solid
Xian-Jun Yu 198
Not applicableStudy completedNCT05543096
What this trial is testing

PMCF Study for Cardiology Access Procedures

Who this might be right for
Coronary Artery Disease
Cordis US Corp. 200
Testing effectiveness (Phase 2)Looking for participantsNCT07109323
What this trial is testing

Autologous Transplantation Combined With BCMA CAR-T in the Treatment of UHR-MM

Who this might be right for
Ultra High Risk mm (uhr-mm), 18-70 Years Old, Suitable for ASCT. And Meet Any of the Following uhr-mm DefinitionsCytogenetics Ultra High RiskPrimary Refractory+4 more
Institute of Hematology & Blood Diseases Hospital, China 50
Not applicableLooking for participantsNCT04441983
What this trial is testing

Foot/Ankle At 7T MRI

Who this might be right for
Plantar Plate Tear
Balgrist University Hospital 80
Testing effectiveness (Phase 2)Ended earlyNCT04023331
What this trial is testing

67Cu-SARTATE™ Peptide Receptor Radionuclide Therapy Administered to Pediatric Patients With High-Risk, Relapsed, Refractory Neuroblastoma

Who this might be right for
NeuroblastomaRelapsed NeuroblastomaRefractory Neuroblastoma
Clarity Pharmaceuticals Ltd 21
Load More Results